Effects of db-cAMP and theophylline on Concanavalin A binding site distribution on transformed and protease-treated cell lines.
D000241:Adenosine / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology*; D002087:Butyrates / Q000494:pharmacology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D002471:Cell Transformation, Neoplastic; D003208:Concanavalin A / Q000378:metabolism; D006152:Cyclic GMP / Q000494:pharmacology; D011952:Receptors, Concanavalin A / Q000187:drug effects*; D011955:Receptors, Drug / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology*; D014357:Trypsin / Q000494:pharmacology
D002087:Butyrates; D011952:Receptors, Concanavalin A; D011955:Receptors, Drug; D003208:Concanavalin A; D000249:Adenosine Monophosphate; D003994:Bucladesine; D013806:Theophylline; D014357:Trypsin; D006152:Cyclic GMP; D000241:Adenosine